Baird analyst Brian Skorney maintains Outperform on Sarepta Therapeutics (NASDAQ: SRPT) price target of $202.00.The analyst remains bullish on the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE